1. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
   Tze-Sian Chan et al, 2019, Frontiers in Oncology CrossRef
2. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
   Masahiro Uehara et al, 2024, Cancer Drug Resistance CrossRef
3. Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
   Yali Fan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
   Hongmei Cui et al, 2021, Frontiers in Pharmacology CrossRef
5. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
   Malihe Rezaee et al, 2023, Frontiers in Pharmacology CrossRef
6. Ginsenoside Re Suppress the Proliferation and Migration of MCF-7 Human Breast Cancer Cells
   Jin-Nyoung Ho, 2024, Journal of the Korean Society of Food Science and Nutrition CrossRef
7. The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer
   Pande Kadek Aditya Prayudi et al, 2023, Clinical and Experimental Obstetrics & Gynecology CrossRef
8. RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer
   Gwan Hee Han et al, 2022, The Journal of Gene Medicine CrossRef
9. Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
   Qing-Quan Li et al, 2009, Clinical Cancer Research CrossRef
10. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC
    Kathrin Böpple et al, 2024, Cell Death & Disease CrossRef
11. Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022
    Sindy Cabarca et al, 2024, Frontiers in Oncology CrossRef
12. Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1
    Emilie Bousquet et al, 2009, Cancer Research CrossRef
13. Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Tzu-Hua Chang et al, 2011, American Journal of Respiratory and Critical Care Medicine CrossRef
14. The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
    Jihye Seo et al, 2021, Archives of Pharmacal Research CrossRef
15. Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
    Zhiwei Wang et al, 2009, Cancer Research CrossRef
16. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
    Antonio Hrvat et al, 2024, Frontiers in Immunology CrossRef